oxazolidin-2-one has been researched along with Cancer of Kidney in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Büttner, M; Hupe, MC; Imkamp, F; Kuczyk, MA; Merseburger, AS; Tabrizi, PF | 1 |
Beshir, AB; Fenteany, G; Mc Henry, KT; Montesano, R; Tang, HH; Yeung, KC; Zhu, S | 1 |
Afif, C; Gokaslan, Z; Hachem, R; Raad, I | 1 |
3 other study(ies) available for oxazolidin-2-one and Cancer of Kidney
Article | Year |
---|---|
Hemopatch
Topics: Hemostatics; Humans; Kidney Neoplasms; Nephrectomy; Oxazolidinones; Postoperative Complications; Prospective Studies; Reproducibility of Results; Retrospective Studies; Surgeons; Treatment Outcome | 2021 |
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Topics: Adherens Junctions; Animals; Breast Neoplasms; Cadherins; Cell Movement; Cell-Matrix Junctions; Dogs; Down-Regulation; Epithelial Cells; Extracellular Matrix; Extracellular Matrix Proteins; Humans; Integrin beta1; Kidney Neoplasms; Membrane Proteins; Oxazolidinones; Phosphatidylethanolamine Binding Protein; Phosphoproteins; Protein Kinase Inhibitors; raf Kinases; RNA Interference; Tumor Cells, Cultured; Up-Regulation; Wound Healing; Zonula Occludens-1 Protein | 2008 |
Successful treatment of vancomycin-resistant Enterococcus meningitis with linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Carcinoma, Renal Cell; Cerebellar Neoplasms; Cerebrospinal Fluid; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Kidney Neoplasms; Linezolid; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Treatment Outcome; Vancomycin Resistance; Ventriculostomy | 2001 |